Cargando…
Osterix promotes the migration and angiogenesis of breast cancer by upregulation of S100A4 expression
As a key transcription factor required for bone formation, osterix (OSX) has been reported to be overexpressed in various cancers, however, its roles in breast cancer progression remain poorly understood. In this study, we demonstrated that OSX was highly expressed in metastatic breast cancer cells....
Autores principales: | Qu, Shuang, Wu, Jiahui, Bao, Qianyi, Yao, Bing, Duan, Rui, Chen, Xiang, Li, Lingyun, Yuan, Hongyan, Jin, Yucui, Ma, Changyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349213/ https://www.ncbi.nlm.nih.gov/pubmed/30450809 http://dx.doi.org/10.1111/jcmm.14012 |
Ejemplares similares
-
Upregulated osterix promotes invasion and bone metastasis and predicts for a poor prognosis in breast cancer
por: Yao, Bing, et al.
Publicado: (2019) -
Correction to: Upregulated osterix promotes invasion and bone metastasis and predicts for a poor prognosis in breast cancer
por: Yao, Bing, et al.
Publicado: (2022) -
MiR‐664‐3p suppresses osteoblast differentiation and impairs bone formation via targeting Smad4 and Osterix
por: Xu, Yuexin, et al.
Publicado: (2021) -
Osterix acetylation at K307 and K312 enhances its transcriptional activity and is required for osteoblast differentiation
por: Lu, Jianlei, et al.
Publicado: (2016) -
miR-27a-3p negatively regulates osteogenic differentiation of MC3T3-E1 preosteoblasts by targeting osterix
por: Xu, Yuexin, et al.
Publicado: (2020)